EDITSCD & ERN-EuroBloodNet webinar: Safety of CRISPR/Cas9

ERN-EuroBloodNet and the EDITSCD Consortium is launching the fifth webinar of the series of webinars regarding gene therapy and genome editing approaches for SCD. 

This fifth session will be led by Dr. Ayal Hendel (Bar Ilan University) and Dr. Tony Cathomen (University of Freiburg) who will give an overview on the safety of CRISPR/Cas9 tools.